BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31675375)

  • 1. NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.
    Darracq A; Pak H; Bourgoin V; Zmiri F; Dellaire G; Affar EB; Milot E
    PLoS Genet; 2019 Nov; 15(11):e1008463. PubMed ID: 31675375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
    Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
    Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.
    Arber DA; Chang KL; Lyda MH; Bedell V; Spielberger R; Slovak ML
    Hum Pathol; 2003 Aug; 34(8):809-13. PubMed ID: 14506644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
    Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
    Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein.
    Yoneda-Kato N; Fukuhara S; Kato J
    Oncogene; 1999 Jun; 18(25):3716-24. PubMed ID: 10391679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
    Pasqualucci L; Liso A; Martelli MP; Bolli N; Pacini R; Tabarrini A; Carini M; Bigerna B; Pucciarini A; Mannucci R; Nicoletti I; Tiacci E; Meloni G; Specchia G; Cantore N; Di Raimondo F; Pileri S; Mecucci C; Mandelli F; Martelli MF; Falini B
    Blood; 2006 Dec; 108(13):4146-55. PubMed ID: 16926285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.
    Hitzler JK; Witte DP; Jenkins NA; Copeland NG; Gilbert DJ; Naeve CW; Look AT; Morris SW
    Am J Pathol; 1999 Jul; 155(1):53-9. PubMed ID: 10393836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
    Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
    Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML.
    Falini B; Bigerna B; Pucciarini A; Tiacci E; Mecucci C; Morris SW; Bolli N; Rosati R; Hanissian S; Ma Z; Sun Y; Colombo E; Arber DA; Pacini R; La Starza R; Verducci Galletti B; Liso A; Martelli MP; Diverio D; Pelicci PG; Lo Coco F; Martelli MF
    Leukemia; 2006 Feb; 20(2):368-71. PubMed ID: 16341033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
    Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
    Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
    Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
    Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
    Falini B; Nicoletti I; Martelli MF; Mecucci C
    Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.
    Tan S; Zhang L; Zhong XM; Yang ZL; Zhao LY; Gao YJ; Shao HY; Qin FX; Chen XC; Zhang HJ; Chen H; Wang L
    Int J Med Sci; 2011; 8(4):309-14. PubMed ID: 21611112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chromatin-remodeling complexes B-WICH and NuRD regulate ribosomal transcription in response to glucose.
    Rolicka A; Guo Y; Gañez Zapater A; Tariq K; Quin J; Vintermist A; Sadeghifar F; Arsenian-Henriksson M; Östlund Farrants AK
    FASEB J; 2020 Aug; 34(8):10818-10834. PubMed ID: 32598531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome.
    Matsumoto N; Yoneda-Kato N; Iguchi T; Kishimoto Y; Kyo T; Sawada H; Tatsumi E; Fukuhara S
    Leukemia; 2000 Oct; 14(10):1757-65. PubMed ID: 11021751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.
    Yoneda-Kato N; Kato JY
    Mol Cell Biol; 2008 Jan; 28(1):422-34. PubMed ID: 17967869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.